Optimizing SPAF management in AF patients with history of stroke or TIA: approaches to acute and long-term treatment with NOACs in patients with AF-associated cerebral thrombosis.
Take home messages and a near future roadmap for optimizing new oral anticoagulant-based stroke prevention in atrial fibrillation management: from risk to remedy.
New frontiers and treatment paradigms for stroke prevention in atrial fibrillation: translating landmark trials, ESC Guidelines, and expert-based analysis to the front lines of cardiovascular care for patients with nonvalvular atrial fibrillation
Speakers:
Professor J. Camm, Doctor S. Goldhaber, Professor W. Hacke, Professor J. Le Heuzey, Professor A. Kakkar